A market failure has prevented the development of vaccines against Ebola, MERS and other viruses. Ironically, emerging data suggest these vaccines might be quite straightforward to develop to licensure.
A market failure has prevented the development of vaccines against Ebola, MERS and other viruses. Ironically, emerging data suggest these vaccines might be quite straightforward to develop to licensure.